These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3940525)

  • 21. [Treatment of vulvovaginitis in children and adolescents with metronidazole].
    Scharp H; Amon K
    Zentralbl Gynakol; 1984; 106(6):374-8. PubMed ID: 6609502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effectiveness of metronidazole, Fasygin and Pimafucin in trichomoniasis. A comparative study].
    Rzempołuch E; Cwik F; Szymanska A; Lubelska K
    Pol Tyg Lek; 1976 Nov; 31(47):2021-3. PubMed ID: 1087011
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction of 2-, 4- and 5-nitroimidazole drugs by hydrogenase 1 in Clostridium pasteurianum.
    Church DL; Rabin HR; Laishley EJ
    J Antimicrob Chemother; 1990 Jan; 25(1):15-23. PubMed ID: 2180890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of metronidazole, tinidazole and dimetridazole in eliminating trichomonads from laboratory mice.
    Roach PD; Wallis PM; Olson ME
    Lab Anim; 1988 Oct; 22(4):361-4. PubMed ID: 3230872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitroimidazoles: in vitro activity and efficacy in anaerobic infections.
    Tally FP; Goldin B; Sullivan NE
    Scand J Infect Dis Suppl; 1981; 26():46-53. PubMed ID: 6941456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of metronidazole on anaerobic bacteria and protozoa.
    Müller M
    Surgery; 1983 Jan; 93(1 Pt 2):165-71. PubMed ID: 6849201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on the therapeutic effect of tinidazole ("Fasigyn") during treatment of urogenital trichomonas infections in women and men (with comparative laboratory studies on the effect of metronidazole and tinidazole)].
    Berić B; Pribicević V; Djordjević M; Pavlović N
    Zentralbl Gynakol; 1978; 100(24):1594-9. PubMed ID: 742252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaerobic reduction of nitroimidazoles by reduced flavin mononucleotide and by xanthine oxidase.
    Clarke ED; Wardman P; Goulding KH
    Biochem Pharmacol; 1980 Oct; 29(19):2684-7. PubMed ID: 6893549
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening.
    Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ
    Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinidazole and metronidazole pharmocokinetics in man and mouse.
    Taylor JA; Migliardi JR; Von Wittenau MS
    Antimicrob Agents Chemother (Bethesda); 1969; 9():267-70. PubMed ID: 5396499
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy of new nitroimidazoles for experimental trichomoniasis, amebiasis, and trypanosomiasis.
    Cuckler AC; Malanga CM; Conroy J
    Am J Trop Med Hyg; 1970 Nov; 19(6):916-25. PubMed ID: 4321789
    [No Abstract]   [Full Text] [Related]  

  • 32. Metronidazole resistance and nim genes in anaerobes: A review.
    Alauzet C; Lozniewski A; Marchandin H
    Anaerobe; 2019 Feb; 55():40-53. PubMed ID: 30316817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis.
    Yarlett N; Yarlett NC; Lloyd D
    Biochem Pharmacol; 1986 May; 35(10):1703-8. PubMed ID: 3486660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation.
    Crossnoe CR; Germanas JP; LeMagueres P; Mustata G; Krause KL
    J Mol Biol; 2002 Apr; 318(2):503-18. PubMed ID: 12051855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiological study of copiamycin.
    Seiga K; Yamaji K
    Appl Microbiol; 1971 Jun; 21(6):986-9. PubMed ID: 5105682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new antitrichomonal agent, tinidazole].
    Di Carlo R
    G Batteriol Virol Immunol; 1974; 67(7-12):257-72. PubMed ID: 4377559
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fundamentals of the chemotherapy of trichomoniasis and amebiasis with ornidazole].
    Richle R; Scholer HJ; Angehrn P; Fernex M; Hummler H; Jeunet F; Schärer K; Schüpbach K; Schwartz DE
    Arzneimittelforschung; 1978; 28(4):612-25. PubMed ID: 581938
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of Metronidazole in pregnant women.
    Amon I; Amon K; Franke G; Mohr C
    Chemotherapy; 1981; 27(2):73-9. PubMed ID: 7471904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reductive metabolism and activation of benznidazole, a drug against Chagas' disease.
    Masana M; de Toranzo EG; Castro JA
    Dev Toxicol Environ Sci; 1983; 11():383-6. PubMed ID: 6689570
    [No Abstract]   [Full Text] [Related]  

  • 40. Reductive activation of nitroheterocyclic compounds.
    Tocher JH
    Gen Pharmacol; 1997 Apr; 28(4):485-7. PubMed ID: 9147012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.